America’s healthcare networks are under attack
The stakes, impact and cost of cybercrime is rising and we must employ the right tech to fight back.
Uncategorized
Trends in telehealth: Integrating physicians into virtual care
Many physicians are interested in working in telehealth, whether it’s part-time, full-time or gig work. Here are the factors to consider when integrating physicians into a virtual care program.
Trends in telehealth: Integrating physicians into virtual care Read More »
Los biomas: ecosistemas globales y tesoros de biodiversidad
En nuestro planeta diverso y dinámico, los biomas representan vastas regiones con características climáticas y ecológicas únicas que albergan una asombrosa diversidad de vida. Desde las exuberantes selvas tropicales hasta los áridos desiertos, los biomas son …
Los biomas: ecosistemas globales y tesoros de biodiversidad Read More »
Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranor
Inventiva announced the publication in the peer-reviewed scientific journal Nature Communications of additional results from its NATIVE Phase IIb clinical trial demonstrating the improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranor.
Leads Biolabs is Proud to Announce its Participation in the 2024 ASCO Annual Meeting with One Oral Presentation and Two Posters.
The 2024 American Society of Clinical Oncology Annual Meeting will be held in Chicago from May 31 to June 4, 2024.
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results
QIAGEN announced that the U.S. Food and Drug Administration has cleared the QIAstat-Dx Respiratory Panel Plus syndromic test for clinical use.
Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio
Almirall, S.A. a global biopharmaceutical company based in Barcelona, announced its financial results from the first quarter 2024.
Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA
Zai Lab Limited announced that the National Medical Products Administration in China has approved the New Drug Application for AUGTYRO™ for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small-cell lung cancer.
Karl Landsteiner: Padre de la tipificación sanguínea
La historia de la medicina está marcada por figuras visionarias cuyos descubrimientos han transformado radicalmente nuestra comprensión y práctica de la salud. Entre estos gigantes se encuentra Karl Landsteiner, un eminente científico cuyos trabajos revolucionaron el camp …
Karl Landsteiner: Padre de la tipificación sanguínea Read More »
Criovolcanes: Las misteriosas maravillas del universo congelado
Más allá de los planetas rocosos y los gigantes gaseosos se encuentran mundos helados que albergan fenómenos geológicos extraordinarios. Entre estos, destacan los criovolcanes, misteriosas estructuras que desafían nuestra comprensión de la actividad volc&aac …
Criovolcanes: Las misteriosas maravillas del universo congelado Read More »